✦ LIBER ✦

Clinical Predictors of Oxidized Low-Density Lipoprotein in Patients With Coronary Artery Disease

✍ Scribed by Lori Mosca MD; MPH; PhD; Melvyn Rubenfire MD; Tom Tarshis MPH; Alan Tsai PhD; Thomas Pearson MD; MPH; PhD

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autoantibodies to oxidized low-density l

✍ Yaniv Sherer; Alexander Tenenbaum; Miri Blank; Joseph Shemesh; Dror Harats; Enri 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 73 KB

Oxidized low-density lipoprotein as a pr

✍ Nina Johnston; Tomas Jernberg; Bo Lagerqvist; Agneta Siegbahn; Lars Wallentin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Serum levels of remnant lipoprotein chol

✍ Makoto Hiki; Kazunori Shimada; Hirotoshi Ohmura; Takashi Kiyanagi; Atsumi Kume; 📂 Article 📅 2009 🏛 Elsevier 🌐 Japanese ⚖ 527 KB

Susceptibility of low density lipoprotei

✍ A. Ruelland; F. Paillard; G. Gallou; B. Legras; N. Savoure´; L. Cloarec 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Oxidized Low-Density Lipoprotein, a Two-

✍ Sampath Parthasarathy; Nalini Santanam; Nathalie Augé 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Effect of Ezetimibe/Atorvastatin Combina

✍ Rabih R. Azar; Georges Badaoui; Antoine Sarkis; Mireille Azar; Herminé Aydanian; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 252 KB